Avapro
Links shared publicly online about this topic
Irbesartan in the ACTIVE study
theheart.org — “The study missed its primary end point, but the ACTIVE investigators see a silver lining with irbesartan in AF patients treated with the drug, saying that the secondary reduction in heart-failure hospitalizations is” View full resource at theheart.org
Most Recently Shared on September 1, 2009 at 4:27 pm By:
heartwire: Irbesartan in atrial fibrillation: No overall benefit, but it may prevent later hear.. http://bit.ly/RoyRy #ESC09
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines | NJ.com
nj.com — “The agency said it began a review of a class of drugs known as angiotensin receptor blockers after a recently published study suggested the medicines could be associated with a slight increased risk of cancer. The class of drugs includes some of the top-selling blood pressure drugs, such as Merck’s Cozaar and Avapro, a drug marketed by Bristol-Myers Squibb.” View full resource at nj.com
Most Recently Shared on July 16, 2010 at 1:51 pm By:
RT @cafepharma: FDA takes closer look at possble cancer risks of popular hypertension meds- Star Ledger, NJ Fri, 07/... http://is.gd/duiBH
FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk
drugs.com — “FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk” View full resource at drugs.com
Most Recently Shared on July 16, 2010 at 12:22 am By:
FDA Alert - Angiotensin Receptor Blockers: Ongoing Safety Review for Cancer Risk - http://bit.ly/b2MJfG
Telmisartan (Micardis) Drug Information by MedicineNet.com
medicinenet.com — “Telmisartan (micardis) is an arb prescribed for the treatment of high blood pressure and the prevention of heart attack, stroke, and cardiovascular events in patients at risk.” View full resource at medicinenet.com
Most Recently Shared on January 7, 2010 at 6:45 pm By:
MedicineNet: telmisartan, Micardis http://bit.ly/64aggw Full http://bit.ly/7AQcW1
Medical News: ARB No Help for Cardiac Events in Afib Patients - in Clinical Context, Strokes from MedPage Today
medpagetoday.com — “Lowering blood pressure with irbesartan (Avapro), an angiotensin receptor blocker, did not reduce cardiovascular events in patients with atrial fibrillation, a large, randomized controlled trial showe” View full resource at medpagetoday.com
Most Recently Shared on March 10, 2011 at 2:33 pm By:
ARB No Help for Cardiac Events in Afib Patients (CME/CE) http://bit.ly/eaisni
Medical News: ARB No Help for Cardiac Events in Afib Patients - in Clinical Context, Strokes from MedPage Today
medpagetoday.com — “Lowering blood pressure with irbesartan (Avapro), an angiotensin receptor blocker, did not reduce cardiovascular events in patients with atrial fibrillation, a large, randomized controlled trial showe” View full resource at medpagetoday.com
Most Recently Shared on March 11, 2011 at 3:03 am By:
ARB No Help for Cardiac Events in Afib Patients: http://bit.ly/gfJhTz
I'm allergic to aspirin, so what can I take for my heart? - CNN.com
cnn.com — “I am allergic to aspirin and wonder: If I ever needed a blood thinner or daily aspirin, is there any option for me? There is a history of heart disease in my mother's family. I do take irbesartan (Avapro) for high blood pressure and simvastatin (Zocor) for cholesterol control.” View full resource at cnn.com
Most Recently Shared on April 6, 2011 at 3:18 pm By:
I'm allergic to aspirin, so what can I take for my heart?: I am allergic to aspirin and wonder: If I ever needed... http://bit.ly/fUwEh1
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
RitaRubin
I write about drug safety, the FDA, women's health, to name a few medical topics, for USA TODAY.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement

